RenCa Cells
USD$550.00*
Products are shipped frozen on dry ice in cryotubes. Each cryotube typically contains 3 × 106 cells for adherent lines or 5 × 106 cells for suspension lines (refer to the batch CoA for details).
General information
| Description | RenCa (Renal Carcinoma) cells are a murine renal adenocarcinoma cell line. They are derived from a tumor spontaneously developed in the kidney of a BALB/c mouse, a common inbred strain used in research. RenCa cells are used extensively to study renal cancer biology, tumor immunology, and cancer therapy, including the efficacy of immunotherapeutic agents. The cells are known for their aggressive tumor formation when implanted in syngeneic mice, making them a valuable model for in vivo experiments that aim to mimic cancer progression and metastasis in a controlled laboratory environment. RenCa cells are characterized by a high mitotic index and are able to grow in an anchorage-independent manner, forming colonies in soft agar, which is a hallmark of oncogenic transformation. They display a fibroblast-like morphology and due to their origin in a BALB/c mouse, RenCa cells are particularly useful for research using immunocompetent mice, facilitating studies on the interaction between cancer cells and the immune system. This cell line has been utilized in numerous studies investigating the role of specific immune cells and molecules in tumor growth suppression and the potential for therapeutic intervention. In addition to their use in immunotherapy research, RenCa cells have also served as a tool in the study of cancer metastasis mechanisms, particularly in the context of the renal system. They have been employed to assess the impact of various genes and proteins on tumor invasiveness and metastatic potential, offering insights into the pathways that might be targeted to inhibit cancer spread in renal carcinoma. These features make RenCa a crucial model in both fundamental and translational cancer research. |
|---|---|
| Organism | Mouse |
| Tissue | Kidney |
| Disease | Carcinoma |
| Synonyms | Renca, RENCA, Renal Carcinoma |
Characteristics
| Breed/Subspecies | BALB/c |
|---|---|
| Age | 6 weeks |
| Gender | Male |
| Morphology | Epithelial-like |
| Growth properties | Adherent |
Regulatory Data
| Citation | RenCa (Cytion catalog number 400321) |
|---|---|
| Biosafety level | 1 |
| NCBI_TaxID | 10090 |
| CellosaurusAccession | CVCL_2174 |
| GMO Status | GMO-S1: This murine renal carcinoma cell line (RenCa) contains stable, undefined genetic alterations associated with spontaneous tumorigenesis. The modification renders the line GMO-classified under German rules. This classification applies only within Germany and may differ elsewhere. |
Biomolecular Data
| Tumorigenic | Yes, in syngeneic mice |
|---|---|
| Virus susceptibility | MAP testing negative (Sendai, Ektromelie, Polyoma, K-Virus, Kilham, LCM, M.pulmonis, MVM, Theiler`s GD VII, toolan`s H-1, MHV, RCV/SDA, M-Adenovirus) |
Handling
| Culture Medium | RPMI 1640, w: 2.0 mM stable Glutamine, w: 2.0 g/L NaHCO3 (Cytion article number 820700a) |
|---|---|
| Supplements | Supplement the medium with 10% FBS |
| Dissociation Reagent | Accutase |
| Doubling time | 47 hours |
| Subculturing | Remove the old medium from the adherent cells and wash them with PBS that lacks calcium and magnesium. For T25 flasks, use 3-5 ml of PBS, and for T75 flasks, use 5-10 ml. Then, cover the cells completely with Accutase, using 1-2 ml for T25 flasks and 2.5 ml for T75 flasks. Let the cells incubate at room temperature for 8-10 minutes to detach them. After incubation, gently mix the cells with 10 ml of medium to resuspend them, then centrifuge at 300xg for 3 minutes. Discard the supernatant, resuspend the cells in fresh medium, and transfer them into new flasks that already contain fresh medium. |
| Seeding density | 2 x 104 cells/cm2 |
| Fluid renewal | 2 to 3 times per week |
| Post-Thaw Recovery | Fast. Viability 93%. Allow cells to recover from the freezing process for 24 to 48 hours. |
| Freeze medium | As a cryopreservation medium, we use complete growth medium (including FBS) + 10% DMSO for adequate post-thaw viability, or CM-1 (Cytion catalog number 800100), which includes optimized osmoprotectants and metabolic stabilizers to enhance recovery and reduce cryo-induced stress. |
| Thawing and Culturing Cells |
|
| Incubation Atmosphere | 37°C, 5% CO2, humidified atmosphere. |
| Shipping Conditions | Cryopreserved cell lines are shipped on dry ice in validated, insulated packaging with sufficient refrigerant to maintain approximately −78 °C throughout transit. On receipt, inspect the container immediately and transfer vials without delay to appropriate storage. |
| Storage Conditions | For long-term preservation, place vials in vapor-phase liquid nitrogen at about −150 to −196 °C. Storage at −80 °C is acceptable only as a short interim step before transfer to liquid nitrogen. |
Quality Control & Molecular Analysis
| Sterility | Mycoplasma contamination is excluded using both PCR-based assays and luminescence-based mycoplasma detection methods. To ensure there is no bacterial, fungal, or yeast contamination, cell cultures are subjected to daily visual inspections. |
|---|
Certificate of Analysis (CoA)
| Lot Number | Certificate Type | Date | Catalog Number |
|---|---|---|---|
| 400321-131224 | Certificate of Analysis | 23. May. 2025 | 400321 |
| 400321-1519SF | Certificate of Analysis | 23. May. 2025 | 400321 |
-
Required products
Required products
Antibiotic/Antimycotic Solution (100x)Product Overview
Volume: 100 ml
Storage: ≤-15°C
Sterility: Sterile-filtered
Antibiotic/Antimycotic Solution (100x) is a sterile, ready-to-use concentrate designed to reduce microbial contamination risks in cell culture and related laboratory applications. This 100x solution contains a well-established combination of penicillin, streptomycin, and amphotericin B—providing broad-spectrum antimicrobial activity against Gram-positive and Gram-negative bacteria, yeasts, and filamentous fungi. The formulation is suitable for use in eukaryotic cell cultures, bacterial media, and other contamination-sensitive systems, supporting clean and consistent lab operations.
Application and Benefits Optimized for routine research protocols, this solution is widely used to maintain aseptic conditions in cell culture workflows. It offers reliable performance in contamination-sensitive environments, helping researchers reduce the risk of microbial overgrowth without compromising cell health or experimental reproducibility. The sterile-filtered formulation eliminates the need for additional solubilization steps, supporting streamlined media preparation and reducing variability in daily lab procedures.
Usage and Compatibility To achieve standard working concentrations, dilute the solution 1:100 into your complete culture medium. The product is compatible with a broad range of mammalian cell lines and basal media. With consistent stock availability, researchers benefit from dependable supply continuity and simplified logistics planning. The solution should be stored at ≤ –15 °C and protected from repeated freeze-thaw cycles to maintain stability. For research use only. Not for use in diagnostic or therapeutic procedures. Not for use in humans or animals.USD$45.00*